FT Health Discusses R&D In Health, Features Interview With Head Of European Network Of Rare Disease Organizations

FT Health: Boost for neglected disease funding
The latest issue of the Financial Times’ weekly global health newsletter discusses data from the G-Finder report on funding for neglected diseases research and development (R&D) and highlights an FT report on the future of R&D in health. The newsletter also features an interview with Yann Le Cam, head of Eurordis, the European network of rare disease organizations, who discusses a new report on improving access to medicines, as well as provides a round-up of global health-related news stories (Dodd/Jack, 1/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.